For months now, I've wondered just how Trump was aiming to profit from attacking Tylenol.
You knew it was another #TrumpShakedown because he was personally engaged in it - esp online.
Now, we know why. It was part of driving down the acquisition price (or so, I speculate)
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm https://www.nytimes.com/2025/11/03/health/tylenol-autism-kimberly-clark-kenvue.html?smid=nytcore-android-share
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.